THRIVENT FINANCIAL FOR LUTHERANS - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$169,000
-41.5%
133,429
+0.6%
0.00%
-100.0%
Q3 2021$289,000
-41.6%
132,648
+0.5%
0.00%0.0%
Q2 2021$495,000
+26.6%
132,043
+10.2%
0.00%0.0%
Q1 2021$391,000
-50.6%
119,870
-48.4%
0.00%
-50.0%
Q4 2020$792,000
-16.4%
232,0930.0%0.00%
-33.3%
Q3 2020$947,000
-3.0%
232,093
-19.6%
0.00%0.0%
Q2 2020$976,000
+45.7%
288,708
+0.5%
0.00%
+50.0%
Q1 2020$670,000
+104.9%
287,300
+219.4%
0.00%
+100.0%
Q4 2019$327,000
-56.0%
89,955
+0.3%
0.00%
-50.0%
Q3 2019$744,000
+4.3%
89,670
+8.3%
0.00%0.0%
Q2 2019$713,000
-14.1%
82,765
+6.6%
0.00%
-33.3%
Q1 2019$830,000
+32.6%
77,626
+8.4%
0.00%
+50.0%
Q4 2018$626,000
-43.0%
71,594
+9.5%
0.00%
-33.3%
Q3 2018$1,098,000
-18.5%
65,366
+1.7%
0.00%
-25.0%
Q2 2018$1,347,000
+41.9%
64,243
+8.9%
0.00%
+33.3%
Q1 2018$949,000
-15.3%
59,009
-0.2%
0.00%
-25.0%
Q4 2017$1,120,000
+71.3%
59,111
+27.2%
0.00%
+100.0%
Q3 2017$654,000
+105.7%
46,480
+8.9%
0.00%
+100.0%
Q2 2017$318,000
+20.0%
42,680
+4.6%
0.00%0.0%
Q1 2017$265,000
+58.7%
40,790
+8.5%
0.00%0.0%
Q4 2016$167,0000.0%37,600
+5.4%
0.00%0.0%
Q3 2016$167,000
-15.7%
35,670
+18.2%
0.00%0.0%
Q2 2016$198,000
+17.9%
30,190
+14.1%
0.00%0.0%
Q1 2016$168,000
+10.5%
26,460
+4.9%
0.00%0.0%
Q4 2015$152,000
-86.9%
25,220
-87.0%
0.00%
-83.3%
Q3 2015$1,157,000
-11.1%
193,460
+1.7%
0.01%
-14.3%
Q2 2015$1,301,000
+14.2%
190,270
+1.4%
0.01%
+16.7%
Q1 2015$1,139,000
-10.6%
187,590
+2.1%
0.01%
-14.3%
Q4 2014$1,274,000
-19.8%
183,800
-5.8%
0.01%
-22.2%
Q3 2014$1,588,000
+11.6%
195,100
+11.5%
0.01%
+12.5%
Q2 2014$1,423,000
+812.2%
175,050
+777.4%
0.01%
+700.0%
Q1 2014$156,000
-9.8%
19,950
+1.8%
0.00%0.0%
Q4 2013$173,000
-88.8%
19,600
-89.4%
0.00%
-90.0%
Q3 2013$1,548,000
-38.0%
184,800
-44.8%
0.01%
-37.5%
Q2 2013$2,498,000334,8000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders